Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01774123 · ClinicalTrials.gov registry record
Optical Coherence Tomography in Multiple Sclerosis Patients
A clinical trial, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- 78
- Enrollment target
NCT01774123: Completed study, sponsored by The Cleveland Clinic.
NCT01774123 is a clinical trial that has completed, run by The Cleveland Clinic. The registered enrollment target is 78 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01774123 has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- 78 participants
- Enrollment target
Study Summary
To evaluate the ability of different spectral domain optical coherence tomography (OCT) devices, as well as different acquisition and analysis packages, to detect disease progression in patients with multiple sclerosis with and without a history of optic neuritis
Primary Outcome
The primary outcome is to determine the thickness of the retinal layers (measured in microns) of optic neuritis-affected eye in MS patients, as compared to controls.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-06 |
What the finished NCT01774123 record still lists
NCT01774123 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 78 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01774123 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01774123 about?
NCT01774123 is a clinical study titled "Optical Coherence Tomography in Multiple Sclerosis Patients". To evaluate the ability of different spectral domain optical coherence tomography (OCT) devices, as well as different acquisition and analysis packages, to detect disease progression in patients with multiple sclerosis with and without a history of optic neuritis
What is the current status of trial NCT01774123?
This trial is currently completed. The enrollment target is 78 participants. The study started on 2012-08. Estimated completion is 2013-06.
Who is sponsoring clinical trial NCT01774123?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia